Published Jan 1, 2016 |
134 Pages |
Pub ID: KLI5816129
The Market for Direct-to-Consumer Genetic Testing and Routine Laboratory Testing
The growth of the direct-to-consumer lab testing healthcare market segment is born out of a paradigm shift among consumers who are seeking greater control over their own healthcare. Kalorama Information's report, The Market for Direct-to-Consumer Genetic Testing and Routine Laboratory Testing, provides the reader with an overview of the U.S. DTC (direct-to-consumer) laboratory testing industry for both advanced genetic tests and routine core laboratory testing.
Direct-to-consumer lab testing is a reality that genetic testing companies and healthcare service providers should be aware of. Several trends are continuing to shape the direct to consumer laboratory testing market including the growing demand for early disease detection and diagnosis, personalized medicine, importance of disease monitoring and expanded technologies. The Market for Direct-to-Consumer Genetic Testing and Routine Laboratory Testing evaluates those trends and provides useful business information.
Market Trends Covered Include:
- U.S. Direct-to-Consumer Laboratory Testing Market Value by Year, 2010-2020
- U.S. Direct-to-Consumer Laboratory Testing Market : Revenues by Type (Routine vs. Genetic)
- Routine and Core Laboratory Testing Market
- DTC Genetic Testing market
- U.S. DTC Laboratory Testing Market, Uninsured Population Utilization
- U.S. Direct-to-Consumer Laboratory Testing, by Target Age, 2020
- Genetic Testing Services Percentage DTC vs. Physician Ordered
Included in The Market for Direct-to-Consumer Genetic Testing and Routine Laboratory Testing are statistics influencing direct-to-consumer lab testing, incidence of diseases in the U.S. and worldwide, demographics; life expectancy, and genetic testing company strategies. Information is presented as a U.S market report. A market summary includes a total U.S. market analysis and analysis by test segment. Also included are competitive profiles of leading direct to consumer laboratory testing providers.
Since the 1980s, consumers have pushed for access to their laboratory tests, but it has been slow to evolve due to concerns that consumers may try to diagnose themselves without understanding how diagnoses' information all fits together. With advances in genetic testing technology, the completion of the sequencing of the human genome and the pressures of capitalism, direct-to-consumer lab testing is becoming increasingly popular. With the increased use of the Internet for medical information, consumers have become medical consumers as well as patients. This has created a change in the doctor/patient relationship as individuals become more knowledgeable about their own health and want more control over their personal information and treatment decisions.
The U.S. direct-to-consumer laboratory testing market is highly competitive in terms of prices, locations, and services offered. Larger genetic testing companies such as Quest Diagnostics and LabCorp have advantages in the genetic testing market due to the wide exposure, large number of locations, and greater financial positions but until recently, had not been directly involved. Smaller, independent laboratories have been the mainstay of the direct to consumer laboratory testing market. Some laboratories, such as 23and Me and have found success in offering specialized genetic testing (ancestral testing) and others have found success operating on a regional basis such as Sonora Quest Laboratories. This report provides an overview of some of the leading market participants in the direct to consumer laboratory testing market.
Leading Genetic Testing Companies:
• Any Lab Test Now.
• Color Genomics
• Direct Laboratory Services
• Gene by Gene
• HealthCheck USA
• Home Access Health Corporation
• Laboratory Corporation of America
• Mapmygenome India
• Positive Bioscience
• Quest Diagnostics
• Request A Test
• Sonora Quest Laboratories
• Walk-In Lab
• Xcode Life Sciences
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.
All market data pertains to the U.S. market at the manufacturers’ level. The base year for data is 2015. Historical data is provided for the years 2010 through 2014, with forecast data provided for 2016 through 2020. Compound annual growth rates (CAGRs) are provided for the 2010-2015 and 2015-2020 periods for each segment covered. The forecasted market analysis through 2020 was largely based on demographic trends, disease trends, new developments, company performance trends, national expansion and recent alliances.